Studies of Outcomes, Risks, Costs, and Benefits
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (Univ of California at Los Angeles; Brown Univ, Providence, RI; Natl Cancer Inst, Bethesda, MD; et al) N Engl J Med 365:395-409, 2011§
Evidence Ranking
• A
Expert Rating
• 3
Abstract
Background
The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening. The advent of lowdose helical computed tomography (CT) altered the landscape of lung-cancer screening, with studies indicating that low-dose CT detects many tumors at early stages. The National Lung Screening Trial (NLST) was conducted to determine whether screening with low-dose CT could reduce mortality from lung cancer.
Methods
From August 2002 through April 2004, we enrolled 53,454 persons at high risk for lung cancer at 33 U.S. medical centers. Participants were randomly assigned to undergo three annual screenings with either low-dose CT (26,722 participants) or single-view posteroanterior chest radiography (26,732). Data were collected on cases of lung cancer and deaths from lung cancer that occurred through December 31, 2009.
Related posts:
of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study
of Cancer: The Next Generation
Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes: A meta-analysis
Administered after Recovery from Neuromuscular Block Increases Upper Airway Collapsibility by Decreasing Genioglossus Muscle Activity in Response to Negative Pharyngeal Pressure
use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal
Neuromuscular Block: Lessons Unlearned. Part I: Definitions, Incidence, and Adverse Physiologic Effects of Residual Neuromuscular Block
Full access? Get Clinical Tree
